State SPAs Reimburse 340B Covered Entities at Actual Acquisition Cost (AAC): Creates Disincentives For 340B Entities to Choose the Lowest Cost Drugs

Since the 2016 Covered Outpatient Drugs final rule, states submitting SPAs have defaulted to AAC to reimburse 340B eligible entities. This removes incentives for 340B clinics to choose drugs that cost less than alternatives.

Click here for more information on each State SPA